compounds 3b, 3d, 3g, 3h and 3i showed the more potent anti-HIV-1 activity with 50% effective concentration (EC 50 ) values of 11.53, 12.53, 15.48, 5.96 and 18.14 mg/ml, and therapeutic index (TI) values of 9.19, 9.34, 7.59, 18.32 and 8.36, respectively. Especially compound 3h exhibited the most potent and promising anti-HIV-1 activity with EC 50 value of 5.96 mg/ml and TI value of 18.32, which was as potent as N- (2-nitrophenyl) indole with EC 50 value of 7.88 mg/ml and TI value of 24.61. 9) From the comparative study, it is possible to draw some preliminary structure-activity relationships on these benzyl phenyl ethers. As indicated in Table 1 , the EC 50 and TI values of 3a, 3b and 3c were 57.99/11.53/29.36 mg/ml, and 3.41/9.19/3.70, respectively. Obviously, introducing chloro group on the para position on the phenyl ring of compound 3a, would lead to give more potent compound than that having ortho-chloro group on the phenyl ring (3b vs. 3c). On the contrary, when nitro group was introduced on the ortho or para position on the phenyl ring of compound 3a, the EC 50 and TI values of the corresponding compounds 3d and 3e were 12.53/53.26 mg/ml, and 9.34/3.43, respectively. The EC 50 and TI values of compounds 3f, having meso-methyl group on the phenyl ring, and 3g, having para-tert-butyl group on the phenyl ring, were 44.87/15.48 mg/ml, and 3.00/7.59, respectively. Consequently, introducing electrondonating group on the para position on the phenyl ring of 3a, would give more potent compound than that having electrondonating group on meso position on the phenyl ring. Meantime, when electron-donating group (tert-butyl group) was introduced on the para position on the phenyl ring of 3a, it will give more potent compound than that having electronwithdrawing group (nitro group) on the para position on the phenyl ring (3g vs. 3e). The EC 50 and TI values of 3a, 3e and 3h were 57.99/53.26/5.96 mg/ml, and 3.41/3.43/18.32, respectively. That is, the TI value of 3h was more than 5 times of those of 3a and 3e, and the EC 50 of 3h was almost decreased 9 times compared with 3a and 3e. Therefore, introducing nitro group on the para position on the benzyl ring of 3a will give more active compound than that having paranitro group on the phenyl ring (3h vs. 3e).
Once the nitro group (electron-withdrawing group) on the para position on the benzyl ring of compound 3h was substituted by the methoxy group (electron-donating group) to give compound 3i, however, the anti-HIV-1 activity of which was decreased more than twice compared with 3h. For example, the EC 50 and TI values of 3h and 3i were 5.96/18.14 mg/ml, and 18.32/8.36, respectively.
Interestingly, when the nitro group was introduced on the para position on the phenyl ring of 3h to give 3j, the anti-HIV-1 activity of which was sharply decreased compared with 3h. For example, The EC 50 and TI values of 3h and 3j were 5.96/58.20 mg/ml, and 18.32/2.91, respectively. The anti-HIV-1 activity of 3h was nearly 10 times of that of 3j. Based upon the above investigation, the nitro group on the para position on the benzyl ring certainly is an important functional group for 3h being good HIV-1 inhibitory activity. In addition, the mechanisms of the anti-HIV-1 function of these compounds, of course, need to be studied further.
Conclusion
In summary, ten single benzyl phenyl ethers were synthesized and evaluated in vitro as HIV-1 inhibitors. Compounds 3b, 3d, 3g, 3h and 3i demonstrated significant anti-HIV-1 activity as displayed in Table 1 ; especially compound 3h showed the most promising and best activity against HIV-1, which will pave the way for further optimal structural modifications of the benzyl phenyl ethers to discover the more potent compounds possessing anti-HIV-1 activity.
Experimental
All the solvents were of analytical grade and the reagents were used as purchased. Thin-layer chromatography (TLC) and preparative thin-layer chromatography (PTLC) were performed with silica gel plates using silica gel 60 GF 254 (Qingdao Haiyang Chemical Co., Ltd.). Melting points were determined on a digital melting-point apparatus and were uncorrected.
1 H-NMR spectra were recorded on a Bruker Avance DMX 400 MHz instrument using TMS as internal standard and CDCl 3 as solvent. EI-MS was carried out with Thermo DSQ GC/MS instrument.
General Procedure for the Synthesis of Benzyl Phenyl Ethers 3a-j The mixture of the appropriate phenols (1, 1.1 mmol), benzyl chloride or substituted benzyl methanesulfonates (2, 1.0 mmol), and anhydrous K 2 CO 3 (3.6 mmol) in acetone (10 ml) was stirred under reflux in an air atmosphere (for benzyl chloride, 0.3 mmol KI was used as a catalyst). When the reaction was complete checked by TLC, the mixture was cooled to r.t., filtered, and purified by preparative TLC to give the pure benzyl phenyl ethers (3a-j), which were all known compounds and characterized by 1 a) Values are means of two separate experiments; b) CC 50 (50% cytotoxic concentration), concentration of drug that causes 50% reduction in total C8166 cell number; c) EC 50 (50% effective concentration), concentration of drug that reduces syncytia formation by 50%; d ) therapeutic index (TI) is a ratio of the CC 50 value/EC 50 value; e) AZT was used as a positive control. 
23)
MTT-Based Cytotoxicity Assay Cellular toxicity of compounds 3a-j on C8166 cells was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method as described previously. 24) Briefly, cells were seeded on 96-well microtiter plate in the absence or presence of various concentrations of compounds in triplicate and incubated at 37°C in a humid atmosphere of 5% CO 2 for 3 d. The supernatants were discarded and MTT reagent (5 mg/ml in PBS) was added to each wells, then incubated for 4 h, 100 ml of 50% N,N-dimethylformamide (DMF)-20% SDS was added. After the formazan was dissolved completely, the plates were read on a BioTek Elx 800 ELISA reader at 595/630 nm. The cytotoxic concentration that caused the reduction of viable C8166 cells by 50% (CC 50 ) was determined from dose-response curve.
Syncytia Assay In the presence of 100 ml various concentrations of compounds, C8166 cells (4ϫ10 5 /ml) were infected with virus HIV-1 IIIB at a multiplicity of infection (M.O.I.) of 0.06. The final volume per well was 200 ml. Control assays were performed without the testing compounds in HIV-1 IIIB infected and uninfected cultures. After 3 d of culture, the cytopathic effect (CPE) was measured by counting the number of syncytia. Percentage inhibition of syncytia formation was calculated and 50% effective concentration (EC 50 ) was calculated. AZT (Sigma) was used as a positive control. Therapeutic index (TI)ϭCC 50 /EC 50 . 25) 
